Position in MDXG
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,016,647
+$806,318 QoQ
Shares Held
1,043,286
+28.4% QoQ
Ownership
0.716%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#20
of 226 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. MDXG ranks #174 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in MDXG
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,016,647 | 1,043,286 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,210,329 | 812,742 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,927,087 | 727,783 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $5,233,294 | 749,756 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $6,477,721 | 1,060,184 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $8,246,506 | 1,085,067 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $10,508,557 | 1,092,366 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,796,779 | 1,150,048 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $9,195,482 | 1,326,910 | Shares | Defined | 2024-10-17 | |
| 2024-03-31 | $14,849,968 | 1,928,568 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $13,923,188 | 1,587,593 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $11,498,754 | 1,577,333 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $8,317,056 | 1,258,254 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,527,472 | 447,940 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $549,372 | 197,617 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $366,808 | 127,809 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $823,329 | 237,272 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,290,334 | 273,957 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $923,012 | 152,817 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $900,860 | 148,657 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,590,393 | 207,066 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $724,213 | 70,312 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $548,722 | 60,432 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||